Pleasanton, Calif.-based Juvaris BioTherapeutics, a biotech developing vaccines and drugs against infectious disease, won a $9 million, five-year government grant to study adjuvants, which are substances that boost the body’s natural immune response. See our story at VentureBeat Life Sciences here.
Trackback URL
